Castellan Group’s Abbott ABT Stock Holding History

Castellan Group’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,474	Closed	-$726K	–	32
2025 Q1	$726K	Buy	+5,474	New	+$697K	0.2%	54

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Castellan Group's ABT Position: Q2 2025 in Review

Castellan Group sold out of Abbott (ABT) in Q2 2025, closing a stake of 5,474 shares — an estimated $726K sold.

Castellan Group first reported a position in ABT in Q1 2025 and held it in 1 quarter. The position peaked at $726K in Q1 2025. 3,184 funds tracked by Wall St. Rank hold ABT as of Q2 2025.

Castellan Group reported no remaining Abbott position as of Q2 2025 after selling out during the quarter.
Castellan Group sold 5,474 Abbott shares in Q2 2025, an estimated $726K.
Castellan Group first reported a position in Abbott in Q1 2025 and held it in 1 quarter.
Castellan Group's Abbott position peaked at $726K in Q1 2025.
3,184 funds tracked by Wall St. Rank held Abbott as of Q2 2025.

Based on Castellan Group's 13F filing for Q2 2025, filed 24 Jul 2025.